| Q41853631 | A role for DNA methylation in regulation of EphA5 receptor expression in the mouse retina |
| Q45355262 | Aberrant EPHB4 gene methylation and childhood acute lymphoblastic leukemia |
| Q35118861 | Association of secondhand smoke exposures with DNA methylation in bladder carcinomas. |
| Q36498110 | C/EBPγ deregulation results in differentiation arrest in acute myeloid leukemia. |
| Q39094566 | DNA methylation of membrane-bound tyrosine phosphatase genes in acute lymphoblastic leukaemia. |
| Q51499838 | DNA methylation-based prognosis and epidrivers in hepatocellular carcinoma. |
| Q40059586 | Differential gene expression profiling linked to tumor progression of splenic marginal zone lymphoma |
| Q35003666 | Dose study of the multikinase inhibitor, LY2457546, in patients with relapsed acute myeloid leukemia to assess safety, pharmacokinetics, and pharmacodynamics |
| Q35017605 | Downregulation of EphA5 by promoter methylation in human prostate cancer |
| Q92106745 | Emerging Roles for Eph Receptors and Ephrin Ligands in Immunity |
| Q38209232 | Eph- and ephrin-dependent mechanisms in tumor and stem cell dynamics |
| Q37971902 | Eph-dependent cell-cell adhesion and segregation in development and cancer. |
| Q26864082 | EphA receptor signaling--complexity and emerging themes |
| Q51808808 | EphA3 targeting reduces in vitro adhesion and invasion and in vivo growth and angiogenesis of multiple myeloma cells. |
| Q37190444 | EphA8 is a prognostic marker for epithelial ovarian cancer |
| Q38878649 | EphB1 Suppression in Acute Myelogenous Leukemia: Regulating the DNA Damage Control System |
| Q36179161 | EphB2 activity plays a pivotal role in pediatric medulloblastoma cell adhesion and invasion |
| Q39354035 | EphB4 promotes or suppresses Ras/MEK/ERK pathway in a context-dependent manner: Implications for EphB4 as a cancer target |
| Q39445033 | EphrinA5 suppresses colon cancer development by negatively regulating epidermal growth factor receptor stability |
| Q38141135 | Epigenetic regulation of cell signaling pathways in acute lymphoblastic leukemia |
| Q37965026 | Epigenetic regulation of miRNA genes in acute leukemia. |
| Q38297582 | Epigenetic roots of immunologic disease and new methods for examining chromatin regulatory pathways |
| Q54211664 | Expression of Eph A4, Eph B2 and Eph B4 receptors in AML. |
| Q36618553 | FOXE3 mutations predispose to thoracic aortic aneurysms and dissections. |
| Q26852415 | Functional genomics lead to new therapies in follicular lymphoma |
| Q37377916 | Genome-wide profiling identifies a DNA methylation signature that associates with TET2 mutations in diffuse large B-cell lymphoma |
| Q35528643 | High VLA-4 expression is associated with adverse outcome and distinct gene expression changes in childhood B-cell precursor acute lymphoblastic leukemia at first relapse |
| Q42394189 | Integrative epigenomic analysis identifies biomarkers and therapeutic targets in adult B-acute lymphoblastic leukemia |
| Q37452286 | Loss of expression of EphB1 protein in serous carcinoma of ovary associated with metastasis and poor survival |
| Q38336376 | Methyl-CpG binding column-based identification of nine genes hypermethylated in colorectal cancer |
| Q60921273 | Methylation of the first exon in the erythropoietin receptor gene does not correlate with its mRNA and protein level in cancer cells |
| Q38460190 | Mining for novel tumor suppressor genes using a shortest path approach |
| Q34256273 | Mining the cancer genome uncovers therapeutic activity of EphA7 against lymphoma. |
| Q58130251 | New genetic players in late-onset Alzheimer's disease: Findings of genome-wide association studies |
| Q37637014 | Next generation sequencing: advances in characterizing the methylome |
| Q36396570 | NotI microarrays: novel epigenetic markers for early detection and prognosis of high grade serous ovarian cancer |
| Q36881958 | PRC2 overexpression and PRC2-target gene repression relating to poorer prognosis in small cell lung cancer |
| Q37633690 | Paradoxes of the EphB1 receptor in malignant brain tumors. |
| Q34364217 | Peritumoral small ephrinA5 isoform level predicts the postoperative survival in hepatocellular carcinoma |
| Q92979168 | Polycomb-mediated repression of EphrinA5 promotes growth and invasion of glioblastoma |
| Q38327984 | Preclinical activity of LBH589 alone or in combination with chemotherapy in a xenogeneic mouse model of human acute lymphoblastic leukemia. |
| Q38008491 | Regulation and misregulation of Eph/ephrin expression |
| Q39350173 | Significance of Inactivated Genes in Leukemia: Pathogenesis and Prognosis |
| Q36081601 | Single- and Bayesian Multi-Marker Genome-Wide Association for Haematological Parameters in Pigs. |
| Q24294856 | The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma |
| Q57286200 | The modular network structure of the mutational landscape of Acute Myeloid Leukemia |
| Q39481878 | The putative tumor suppressor gene EphA7 is a novel BMI-1 target |
| Q38174793 | Therapeutic targeting of EPH receptors and their ligands |
| Q49565598 | lncRNA BC005927 upregulates EPHB4 and promotes gastric cancer metastasis under hypoxia |